Acquisition to enhance Lundbeck’s neuroscience pipeline

Phase 2 study of TG4001 shows promise in cervical cancer patients

Sheffield cardiologists demonstrate cutting-edge TAVI procedure

Teclistamab offers hope for patients exhausting treatment options

New investment to advance gene therapies for kidney diseases

New vaccine aims to protect older adults from severe flu complications

Real-world studies show effectiveness of mogamulizumab in routine practice

AviadoBio to receive up to £1.8 billion in potential payments

Biotech company moves forward with phase 2 trial for precision cancer surgery

Scottish Medicines Consortium recommends pembrolizumab